LONG-TERM MAINTENANCE OF IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS OF THE RAPID-AXSPA STUDY

被引：1
|
作者：
Sieper, J. [1 ]
Kivitz, A. [2 ]
van Tubergen, A. [3 ]
Deodhar, A. [4 ]
Coteur, G. [5 ]
Singh, P. [6 ]
Landewe, R. [7 ]
机构：
[1] Univ Hosp Charite, Berlin, Germany
[2] Altoona Ctr Clin Res, Duncansville, PA USA
[3] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Monheim, Germany
[7] Amsterdam & Atrium Med Ctr, Heerlen, Netherlands
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1523
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A569 / A569
页数：1
相关论文
共 50 条
  • [1] LONG-TERM MAINTENANCE OF IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK RESULTS OF THE RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Szegvari, B.
    Nurminen, T.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A385 - A385
  • [2] CONTINUED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY WITH CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS FROM THE RAPID-AXSPA STUDY
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A570 - A570
  • [3] CERTOLIZUMAB PEGOL IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Harris, K.
    Nurminen, T.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A595 - A595
  • [4] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL
    Sieper, J.
    Rudwaleit, M.
    van der Heijde, D.
    Maksymowych, W.
    Dougados, M.
    Mease, P. J.
    Braun, J.
    Deodhar, A.
    Hoepken, B.
    Nurminen, T.
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 719 - 720
  • [5] RAPID IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS: 24-WEEK RESULTS OF RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Woltering, F.
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 287 - 287
  • [6] EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK RESULTS OF RAPID-AXSPA STUDY
    Landewe, R.
    Rudwaleit, M.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Braun, J.
    Deodhar, A.
    Stach, C.
    Hoepken, B.
    Coteur, G.
    Kielar, D.
    Fichtner, A.
    Arledge, T.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 86 - 87
  • [7] Effect Of Certolizumab Pegol Over 48 Weeks In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Landewe, Robert B. M.
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Dougados, Maxime
    Mease, Philip J.
    Reveille, John D.
    Walsh, Jessica
    Kivitz, Alan J.
    Maksymowych, Walter P.
    Braun, Juergen
    Deodhar, Atul A.
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S767 - S767
  • [8] Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    van der Heijde, Desiree
    Dougados, Maxime
    Mease, Phillip
    Reveille, John
    Walsh, Jessica
    Kivitz, Alan
    Braun, Juergen
    Deodhar, Atul
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1496 - 1497
  • [9] RAPID IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK RESULTS OF A PHASE 3 DOUBLE BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Woltering, F.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A227 - A227
  • [10] Four Year Imaging Outcomes in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol, Including Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    van der Heijde, Desiree
    Baraliakos, Xenofon
    Hermann, Kay-Geert
    Landewe, Robert
    Machado, Pedro
    Maksymowych, Walter
    Davies, Owen
    de Peyrecave, Natasha
    Hoepken, Bengt
    Bauer, Lars
    Nurminen, Tommi
    Braun, Juergen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345